Target Name: MIR613
NCBI ID: G693198
Review Report on MIR613 Target / Biomarker Content of Review Report on MIR613 Target / Biomarker
MIR613
Other Name(s): hsa-miR-613 | hsa-mir-613 | MIRN613 | MicroRNA 613 | microRNA 613

MIR613: A Potential Drug Target and Biomarker for Various Diseases

MIR613 (hsa-miR-613) is a microRNA (miRNA) that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders.

MIR613 is a non-coding RNA molecule that contains 613 base pairs of RNA. It is expressed in various tissues and cells in the human body and has been shown to play a role in regulating gene expression. Studies have shown that MIR613 can interact with other miRNAs and affect their stability and translation efficiency.

One of the unique features of MIR613 is its expression pattern. MIR613 is typically expressed in the brain and other highly differentiated tissues, but its levels are relatively low. This is important because MIR613 has been shown to play a role in the regulation of cellular processes that are specific to these tissues, such as cell growth, differentiation, and survival.

In addition to its expression pattern, MIR613 has also been shown to play a role in the regulation of cellular processes that are relevant to a wide range of diseases. For example, MIR613 has been shown to be involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed. This is important because angiogenesis is a critical process for the development and progression of many diseases, including cancer, neurodegenerative diseases, and psychiatric disorders.

MIR613 has also been shown to be involved in the regulation of cellular processes that are relevant to psychiatric disorders. For example, MIR613 has been shown to play a role in the regulation of anxiety and depression, as well as in the regulation of neurotransmitter systems that are involved in mood and emotion. This is important because these disorders are often associated with disruptions in the regulation of cellular processes that are critical to normal brain function.

In addition to its potential role in the regulation of psychiatric disorders, MIR613 has also been shown to be involved in the regulation of cancer. For example, MIR613 has been shown to play a role in the regulation of cell proliferation and the inhibition of apoptosis, which is the process by which cells die when they have reached a certain level of dysfunction. This is important because cancer is a disease that is characterized by the uncontrolled proliferation and survival of cells, and the regulation of these processes is critical for the development and progression of cancer.

Overall, MIR613 is a microRNA that has been shown to play a critical role in the regulation of various cellular processes that are relevant to a wide range of diseases. Its expression pattern and its involvement in the regulation of angiogenesis, anxiety and depression, neurotransmitter systems, and cancer make it an attractive drug target and biomarker for further study. Further research is needed to fully understand the role of MIR613 in these processes and to develop effective therapies that target this microRNA.

Protein Name: MicroRNA 613

The "MIR613 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR613 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR6130 | MIR6131 | MIR6132 | MIR6133 | MIR6134 | MIR614 | MIR615 | MIR616 | MIR6165 | MIR617 | MIR618 | MIR619 | MIR620 | MIR621 | MIR622 | MIR623 | MIR624 | MIR625 | MIR626 | MIR627 | MIR628 | MIR629 | MIR630 | MIR631 | MIR632 | MIR633 | MIR634 | MIR635 | MIR636 | MIR637 | MIR638 | MIR639 | MIR640 | MIR641 | MIR642A | MIR642B | MIR643 | MIR644A | MIR645 | MIR646 | MIR646HG | MIR647 | MIR648 | MIR649 | MIR6499 | MIR650 | MIR6500 | MIR6501 | MIR6502 | MIR6503 | MIR6504 | MIR6505 | MIR6506 | MIR6507 | MIR6508 | MIR6509 | MIR651 | MIR6510 | MIR6511A1 | MIR6511A2 | MIR6511A3 | MIR6511A4 | MIR6511B1 | MIR6511B2 | MIR6512 | MIR6513 | MIR6514 | MIR6515 | MIR6516 | MIR652 | MIR653 | MIR654 | MIR655 | MIR656 | MIR657 | MIR658 | MIR659 | MIR660 | MIR661 | MIR662 | MIR663A | MIR663AHG | MIR663B | MIR664A | MIR664B | MIR665 | MIR668 | MIR670 | MIR671 | MIR6715A | MIR6715B | MIR6716 | MIR6717 | MIR6718 | MIR6719 | MIR6720 | MIR6721 | MIR6722 | MIR6724-1 | MIR6726